Treating Heart Disease in Vescell

VesCell has been used to treat patients suffering from cardiomyopathy, coronary artery disease (also known as angina or ischemic heart disease), peripheral artery disease (PAD), and congestive heart failure (CHF).

Many candidates have exhausted other treatment options. In most cases, VesCell can be used in together with angioplasty and coronary artery bypass graft surgery. VesCell stem cell therapy might also be a viable alternative for patients suffering from other medical conditions rendering conventional treatment impossible.

The first step is a thorough medical screening by experienced stem cell cardiologists to determine if the therapy will help the patient, and, if so, which treatment is best. After being accepted for treatment, the patient travels to a hospital where a cardiologist determines where to implant the cells. Upon arrival in Bangkok, he is she will be met at the airport by a Patient Care Coordinator (PCC) and taken to the residence on hospital grounds. The coordinator will help the patient register and get settled. The PCC will be with the patient for travels between the hotel and the hospital and will never be more than phone Vescell’s laboratory in Israel.

Though the patient’s blood contains stem cells, there are far too few to use for treatment. VesCell uses special processes developed by TheraVitae to isolate and multiply the stem cells, increasing their numbers from 20,000 to 20 million. These cells are sent back to the hospital where they are implanted into either one or more of coronary arteries or are injected directly into the heart muscle. The patient spends the next few days under observation before returning home. Patients usually stay about 14 - 20 days.

VesCell therapy cannot cure heart disease; however, in the majority of patients it can substantially improve blood flow to the heart. The patient experiences fewer chest pains and a dramatic increase in physical abilities. In just a month after treatment, patients feel an improvement in quality of life and are again able once again to enjoy activities restricted by their illness.

The risks of this procedure are similar to those of an angioplasty or minimally invasive heart surgery (not open-heart surgery).